160 related articles for article (PubMed ID: 12065071)
21. Differential effects of guanine nucleotides on [125I]-hCGRP(8-37) binding to porcine lung and human neuroblastoma cell membranes.
Aiyar N; Disa J; Siemens IR; Nambi P
Neuropeptides; 1997 Feb; 31(1):99-103. PubMed ID: 9574846
[TBL] [Abstract][Full Text] [Related]
22. Binding and functional pharmacological characteristics of gepant-type antagonists in rat brain and mesenteric arteries.
Sheykhzade M; Amandi N; Pla MV; Abdolalizadeh B; Sams A; Warfvinge K; Edvinsson L; Pickering DS
Vascul Pharmacol; 2017 Mar; 90():36-43. PubMed ID: 28192258
[TBL] [Abstract][Full Text] [Related]
23. Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries.
Edvinsson L; Sams A; Jansen-Olesen I; Tajti J; Kane SA; Rutledge RZ; Koblan KS; Hill RG; Longmore J
Eur J Pharmacol; 2001 Mar; 415(1):39-44. PubMed ID: 11245850
[TBL] [Abstract][Full Text] [Related]
24. Investigation of the species selectivity of a nonpeptide CGRP receptor antagonist using a novel pharmacodynamic assay.
Hershey JC; Corcoran HA; Baskin EP; Salvatore CA; Mosser S; Williams TM; Koblan KS; Hargreaves RJ; Kane SA
Regul Pept; 2005 Apr; 127(1-3):71-7. PubMed ID: 15680472
[TBL] [Abstract][Full Text] [Related]
25. Characterization of calcitonin gene-related peptide (CGRP) receptors and their receptor-activity-modifying proteins (RAMPs) in human brain microvascular and astroglial cells in culture.
Moreno MJ; Terrón JA; Stanimirovic DB; Doods H; Hamel E
Neuropharmacology; 2002 Feb; 42(2):270-80. PubMed ID: 11804624
[TBL] [Abstract][Full Text] [Related]
26. The calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS blocks CGRP and adrenomedullin vasoactive responses in the microvasculature.
Grant AD; Tam CW; Lazar Z; Shih MK; Brain SD
Br J Pharmacol; 2004 Aug; 142(7):1091-8. PubMed ID: 15237099
[TBL] [Abstract][Full Text] [Related]
27. Characterisation of CGRP receptors in human and porcine isolated coronary arteries: evidence for CGRP receptor heterogeneity.
Gupta S; Mehrotra S; Villalón CM; Garrelds IM; de Vries R; van Kats JP; Sharma HS; Saxena PR; Maassenvandenbrink A
Eur J Pharmacol; 2006 Jan; 530(1-2):107-16. PubMed ID: 16375887
[TBL] [Abstract][Full Text] [Related]
28. Desensitization and re-sensitization of CGRP receptor function in human neuroblastoma SK-N-MC cells.
Pin SS; Xu C; Bahr BA
Eur J Pharmacol; 2007 Dec; 577(1-3):7-16. PubMed ID: 17825280
[TBL] [Abstract][Full Text] [Related]
29. Functional antagonism between endogenous neuropeptide Y and calcitonin gene-related peptide in mesenteric resistance arteries.
De Mey JG; Megens R; Fazzi GE
J Pharmacol Exp Ther; 2008 Mar; 324(3):930-7. PubMed ID: 18055875
[TBL] [Abstract][Full Text] [Related]
30. Non-peptidic antagonists of the CGRP receptor, BIBN4096BS and MK-0974, interact with the calcitonin receptor-like receptor via methionine-42 and RAMP1 via tryptophan-74.
Miller PS; Barwell J; Poyner DR; Wigglesworth MJ; Garland SL; Donnelly D
Biochem Biophys Res Commun; 2010 Jan; 391(1):437-42. PubMed ID: 19914210
[TBL] [Abstract][Full Text] [Related]
31. The preclinical pharmacology of BIBN4096BS, a CGRP antagonist.
Hay DL; Poyner D
Cardiovasc Drug Rev; 2005; 23(1):31-42. PubMed ID: 15867946
[TBL] [Abstract][Full Text] [Related]
32. Functional calcitonin gene-related peptide subtype 2 receptors in porcine coronary arteries are identified as calcitonin gene-related peptide subtype 1 receptors by radioligand binding and reverse transcription-polymerase chain reaction.
Rorabaugh BR; Scofield MA; Smith DD; Jeffries WB; Abel PW
J Pharmacol Exp Ther; 2001 Dec; 299(3):1086-94. PubMed ID: 11714898
[TBL] [Abstract][Full Text] [Related]
33. BIBN4096BS antagonizes human alpha-calcitonin gene related peptide-induced headache and extracerebral artery dilatation.
Petersen KA; Lassen LH; Birk S; Lesko L; Olesen J
Clin Pharmacol Ther; 2005 Mar; 77(3):202-13. PubMed ID: 15735614
[TBL] [Abstract][Full Text] [Related]
34. BIBN4096BS is a potent competitive antagonist of the relaxant effects of alpha-CGRP on human temporal artery: comparison with CGRP(8-37).
Verheggen R; Bumann K; Kaumann AJ
Br J Pharmacol; 2002 May; 136(1):120-6. PubMed ID: 11976276
[TBL] [Abstract][Full Text] [Related]
35. Adrenomedullin-2/intermedin induces cAMP accumulation in dissociated rat spinal cord cells: evidence for the existence of a distinct class of sites of action.
Owji AA; Chabot JG; Dumont Y; Quirion R
J Mol Neurosci; 2008 Jul; 35(3):355-61. PubMed ID: 18418734
[TBL] [Abstract][Full Text] [Related]
36. Differential calcitonin gene-related peptide (CGRP) and amylin binding sites in nucleus accumbens and lung: potential models for studying CGRP/amylin receptor subtypes.
Aiyar N; Baker E; Martin J; Patel A; Stadel JM; Willette RN; Barone FC
J Neurochem; 1995 Sep; 65(3):1131-8. PubMed ID: 7643091
[TBL] [Abstract][Full Text] [Related]
37. Calcitonin gene-related peptide receptor antagonist BIBN4096BS regulates synaptic transmission in the vestibular nucleus and improves vestibular function via PKC/ERK/CREB pathway in an experimental chronic migraine rat model.
Tian R; Zhang Y; Pan Q; Wang Y; Wen Q; Fan X; Qin G; Zhang D; Chen L; Zhang Y; Zhou J
J Headache Pain; 2022 Mar; 23(1):35. PubMed ID: 35260079
[TBL] [Abstract][Full Text] [Related]
38. A key role for transmembrane prolines in calcitonin receptor-like receptor agonist binding and signalling: implications for family B G-protein-coupled receptors.
Conner AC; Hay DL; Simms J; Howitt SG; Schindler M; Smith DM; Wheatley M; Poyner DR
Mol Pharmacol; 2005 Jan; 67(1):20-31. PubMed ID: 15615699
[TBL] [Abstract][Full Text] [Related]
39. From micromolar to nanomolar affinity: a systematic approach to identify the binding site of CGRP at the human calcitonin gene-related peptide 1 receptor.
Rist B; Entzeroth M; Beck-Sickinger AG
J Med Chem; 1998 Jan; 41(1):117-23. PubMed ID: 9438028
[TBL] [Abstract][Full Text] [Related]
40. BIBN4096BS and CGRP(8-37) antagonize the relaxant effects of alpha-CGRP more than those of beta-CGRP in human extracranial arteries.
Verheggen R; Wojtas K; Webel M; Hoffmann S; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2005 May; 371(5):383-92. PubMed ID: 15983761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
